Marinus Pharmaceuticals reported 3M in Trade Debtors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 68.89M 5.41M
ALKERMES ALKS:US 262.33M 7.83M
Amgen AMGN:US $ 5327M 250M
Biogen BIIB:US $ 2003.5M 17.9M
Eisai 4523:JP Y 198940M 9010M
Enanta Pharmaceuticals ENTA:US $ 48.21M 0.74M
Esperion Therapeutics ESPR:US 27.84M 2.73M
Gilead Sciences GILD:US $ 4118M 331M
Intercept Pharmaceuticals ICPT:US $ 27.52M 18.63M
Intra Cellular Therapies ITCI:US $ 46.98M 14.14M
Marinus Pharmaceuticals MRNS:US 3M 511K
Neurocrine Biosciences NBIX:US $ 279M 15.5M
Ptc Therapeutics PTCT:US $ 135.94M 5.34M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M
Sarepta Therapeutics SRPT:US $ 230.28M 33.07M
Supernus Pharmaceuticals SUPN:US $ 158.06M 12.91M
Vertex Pharmaceuticals VRTX:US $ 1332.9M 40.1M
YTE INCY:US $ 682.97M 120.62M